Cell Therapy MDR-101 Produces Functional Immune Tolerance in Kidney Transplant Recipients
Physician's Weekly
JULY 15, 2025
TUESDAY, July 15, 2025 (HealthDay News) — Kidney transplant recipients receiving the investigational cellular product MDR-101 achieved functional immune tolerance for more than two years, according to a study published in the July issue of the American Journal of Transplantation. Dixon B. Kaufman, M.D., Ph.D., from the University of Wisconsin School of Medicine and Public Health in Madison, and colleagues conducted a phase 3 randomized trial to examine MDR-101 for producing immune toleranc
Let's personalize your content